Valion Bio Inc (VBIO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VBIO Annual Balance Sheets →
The balance sheet data below highlights changes in Valion Bio Inc's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent2.11
Cash & Short-term Investments2.00
Accounts receivable0.00
Inventories0.75
Discontinued Operations0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.86
Total Current Assets3.38
Equipment/Property/Plant Net12.72
Goodwill net3.46
Intangible Assets2.24
Deferred Costs, Noncurrent AS0.63
Other Assets, Noncurrent10.04
Operating Lease Right Of Use Asset10.09
Total Assets32.47
Liabilities
Accounts Payable, Current AC0.64
Other Accrued Liabilities, Current2.30
Other Liabilities, Current0.05
Taxes Payable0.02
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.04
Total Current Liabilities3.05
Convertible Debt, Noncurrent LO7.39
Total Long-term Debt7.39
Derivative Liability, Noncurrent DE0.21
Other liabilities, Noncurrent9.94
OperatingLeaseLiabilityNoncurrent9.64
Operating Lease Liability Current0.49
Total Liabilities20.59
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock70.75
Retained Earnings / Accumulated Deficit-66.51
Other Equity0.00
Common Stockholder's Equity4.25
Non-controlling interests & other0.00
Total Stockholder's Equity4.25
Liabilities & Stockholder's Equity32.47
4 historic quarters locked

Sign in to unlock the full Valion Bio Inc balance sheet history.

About Valion Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-028069

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.